Bifogade filer
Kurs
-2,55%
Likviditet
947 MSEK
Kalender
Est. tid* | ||
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-06-25 | - | Årsstämma |
2025-06-05 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2025-04-24 | - | Kvartalsrapport 2025-Q1 |
2025-02-06 | - | Bokslutskommuniké 2024 |
2024-10-17 | - | Kvartalsrapport 2024-Q3 |
2024-07-18 | - | Kvartalsrapport 2024-Q2 |
2024-06-28 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2024-06-27 | - | Årsstämma |
2024-04-18 | - | Kvartalsrapport 2024-Q1 |
2024-02-02 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-20 | - | Kvartalsrapport 2023-Q2 |
2023-06-15 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2023-06-14 | - | Årsstämma |
2023-04-20 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-10-20 | - | Kvartalsrapport 2022-Q3 |
2022-07-19 | - | Kvartalsrapport 2022-Q2 |
2022-06-17 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2022-06-16 | - | Årsstämma |
2022-04-21 | - | Kvartalsrapport 2022-Q1 |
2022-02-03 | - | Bokslutskommuniké 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-07-15 | - | Kvartalsrapport 2021-Q2 |
2021-05-14 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2021-05-12 | - | Årsstämma |
2021-04-22 | - | Kvartalsrapport 2021-Q1 |
2021-02-04 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-16 | - | Kvartalsrapport 2020-Q2 |
2020-06-24 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2020-06-23 | - | Årsstämma |
2020-04-28 | - | Kvartalsrapport 2020-Q1 |
2020-02-06 | - | Bokslutskommuniké 2019 |
2019-10-31 | - | Kvartalsrapport 2019-Q3 |
2019-07-18 | - | Kvartalsrapport 2019-Q2 |
2019-05-23 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2019-05-22 | - | Årsstämma |
2019-04-29 | - | Kvartalsrapport 2019-Q1 |
2019-02-08 | - | Bokslutskommuniké 2018 |
2018-11-01 | - | Kvartalsrapport 2018-Q3 |
2018-07-19 | - | Kvartalsrapport 2018-Q2 |
2018-05-30 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2018-05-29 | - | Årsstämma |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-02-14 | - | Bokslutskommuniké 2017 |
2017-12-22 | - | Extra Bolagsstämma 2017 |
2017-11-14 | - | Kvartalsrapport 2017-Q3 |
2017-07-20 | - | Kvartalsrapport 2017-Q2 |
2017-05-24 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2017-05-23 | - | Årsstämma |
2017-04-26 | - | Kvartalsrapport 2017-Q1 |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-11-21 | - | Extra Bolagsstämma 2016 |
2016-11-09 | - | Kvartalsrapport 2016-Q3 |
2016-07-21 | - | Kvartalsrapport 2016-Q2 |
2016-05-11 | - | Årsstämma |
2016-04-28 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2016-04-27 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-10-28 | - | Kvartalsrapport 2015-Q3 |
2015-08-25 | - | Kvartalsrapport 2015-Q2 |
2015-04-17 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2015-04-16 | - | Årsstämma |
2015-04-16 | - | Kvartalsrapport 2015-Q1 |
2015-02-05 | - | Bokslutskommuniké 2014 |
2014-07-25 | - | Kvartalsrapport 2014-Q2 |
2014-06-04 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2014-06-03 | - | Årsstämma |
2014-03-05 | - | Extra Bolagsstämma 2014 |
2014-02-05 | - | Bokslutskommuniké 2013 |
2013-07-25 | - | Kvartalsrapport 2013-Q2 |
2013-05-07 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2013-05-06 | - | Årsstämma |
2013-02-07 | - | Bokslutskommuniké 2012 |
2012-09-28 | - | Kapitalmarknadsdag 2012 |
2012-07-26 | - | Kvartalsrapport 2012-Q2 |
2012-05-14 | - | Årsstämma |
2012-02-09 | - | Bokslutskommuniké 2011 |
2012-01-09 | - | Extra Bolagsstämma 2011 |
2011-07-28 | - | Kvartalsrapport 2011-Q2 |
2011-05-12 | - | Årsstämma |
2011-05-06 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2010-04-30 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2010-02-10 | - | Bokslutskommuniké 2009 |
2009-07-30 | - | Kvartalsrapport 2009-Q1 |
2009-05-12 | - | Kvartalsrapport 2009-Q2 |
2009-04-30 | - | X-dag ordinarie utdelning HNSA 0.00 SEK |
2009-04-29 | - | Årsstämma |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
With the appointment of Katja Margell as new Head of Corporate Communications Hansa Biopharma seeks to strengthen its communication efforts internally as well as with media and external stakeholders as the Company transitions into a commercial stage biopharmaceutical company.
Lund, Sweden July 16, 2020. Hansa Biopharma ("Hansa"), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company has appointed Katja Margell as new Head of Corporate Communications.
Katja brings extensive corporate communications experience as a former partner at Swedish communications agencies Kreab Worldwide and Hallvarsson & Halvarsson where she focused on strategic, corporate and capital markets communication. Prior to this, Katja was Group Communications Manager at Swedish bank SEB and has also held positions within communications and investor relations in companies in the life science sector. Katja holds double Master's degrees in laws from Vrije Universiteit Brussels and Stockholms University, and she has a background in journalism.
"Katja brings extensive corporate communications experience from leading communications agencies and companies and will be a great addition to the Hansa team as the Company transitions into a commercial stage biopharmaceutical company and expands its proprietary enzyme technology platform beyond transplantation", says Søren Tulstrup, President & CEO of Hansa Biopharma.
Katja will assume the role as Head of Corporate Communications with immediate effect.
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma
Mobile: +46 (0) 709-298 269
E-mail:
Katja Margell, Head of Corporate Communications
Hansa Biopharma
Mobile: +46 (0) 768-198 326
E-mail: